Life Extension Spring Clearance Sale

Brain Tumor References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. Porter KR, McCarthy BJ, Freels S, et al. Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro Oncol. 2010 Jun;12(6):520-7.
  2. Jemel A, Siegel, R, Ward, E. Murray, T, et al. Cancer Statistics, 2008. CA: A Cancer Journal for Clinicians. American Cancer Society. Vol. 58, No. 2, pp. 71-96.
  3. Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol. 2001 Jul;3(3):152-8.
  4. Online Merck Manual. Gliomas. Available at:  http://www.merck.com/mmpe/sec16/ch225/ch225b.html. Accessed 8/2010.
  5. Barrett JR. Critical confluence: gene variants, insecticide exposure may increase childhood brain tumor risk. Environ Health Perspect. 2010 Jan;118(1):A35.
  6. Nielsen SS, McKean-Cowdin R, Farin FM, Holly EA, Preston-Martin S, Mueller BA. Childhood brain tumors, residential insecticide exposure, and pesticide metabolism genes. Environ Health Perspect. 2010 Jan;118(1):144-9.
  7. Efird JT, Holly EA, Cordier S, Mueller BA, Lubin F, Filippini G, et al. Beauty product-related exposures and childhood brain tumors in seven countries: results from the SEARCH International Brain Tumor Study. J Neurooncol. 2005 Apr;72(2):133-47.
  8. Bluhm EC, Zahm SH, Fine HA, Black PM, Loeffler JS, Shapiro WR, et al. Personal hair dye use and risks of glioma, meningioma, and acoustic neuroma among adults. Am J Epidemiol. 2007 Jan 1;165(1):63-71.
  9. Spinelli V, Chinot O, Cabaniols C, Giorgi R, Alla P, Lehucher-Michel MP. Occupational and environmental risk factors for brain cancer: a pilot case-control study in France. Presse Med. 2010 Feb;39(2):e35-44.
  10. Han YY, Kano H, Davis DL, Niranjan A, Lunsford LD. Cell phone use and acoustic neuroma: the need for standardized questionnaires and access to industry data. Surg Neurol. 2009 Sep;72(3):216-22; discussion 222. Epub 2009 Mar 27.
  11. Michaud DS, Holick CN, Batchelor TT, Giovannucci E, Hunter DJ. Prospective study of meat intake and dietary nitrates, nitrites, and nitrosamines and risk of adult glioma. Am J Clin Nutr. 2009 Sep;90(3):570-7.
  12. Dubrow R, Darefsky AS, Park Y, Mayne ST, Moore SC, Kilfoy B, et al. Dietary components related to N-nitroso compound formation: a prospective study of adult glioma. Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1709-22. Epub 2010 Jun 22.
  13. Levenson CW, Figueirôa SM. Gestational vitamin D deficiency: long-term effects on the brain. Nutr Rev. 2008 Dec;66(12):726-9.
  14. Magrassi L, Adorni L, Montorfano G, Rapelli S, Butti G, Berra B, Milanesi G. Vitamin D metabolites activate the sphingomyelin pathway and induce death of glioblastoma cells. Acta Neurochir (Wien). 1998;140(7):707-13; discussion 713-4.
  15. Naveilhan P, Berger F, Haddad K, Barbot N, Benabid AL, et al. Induction of glioma cell death by 1,25(OH)2 vitamin D3: towards an endocrine therapy of brain tumors? J Neurosci Res. 1994 Feb 1;37(2):271-7.
  16. Baudet C, Chevalier G, Naveilhan P, Binderup L, Brachet P, Wion D. Cytotoxic effects of 1 alpha,25-dihydroxyvitamin D3 and synthetic vitamin D3 analogues on a glioma cell line. Cancer Lett. 1996 Feb 27;100(1-2):3-10.
  17. Elias J, Marian B, Edling C, Lachmann B, Noe CR, Rolf SH, et al. Induction of apoptosis by vitamin D metabolites and analogs in a glioma cell line. Recent Results Cancer Res. 2003;164:319-32.
  18. van Ginkel PR, Yang W, Marcet MM, Chow CC, Kulkarni AD, Darjatmoko S, et al. 1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma. J Neurooncol. 2007 Dec;85(3):255-62.
  19. Hakko H, Räsänen P, Niemelä A, Koivukangas J, Mainio A. Season of tumor surgery in relation to deaths among brain tumor patients: does sunlight and month of surgery play a role in brain tumor deaths? Acta Neurochir (Wien). 2009 Nov;151(11):1369-75.
  20. Porojnicu AC, Robsahm TE, Dahlback A, Berg JP, Christiani D, er al. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role? Lung Cancer. 2007 Mar;55(3):263-70.
  21. Stajner I. Season of breast cancer diagnosis and probability of death from breast cancer in the United States. Int J Cancer. 2010 Jun 15;126(12):3010-3.
  22. Robinson D. Season of cancer diagnosis exerts distinct effects upon short- and long-term survival. Int J Cancer. 2010 Jun 15;126(12):3013.
  23. Grant WB. An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking. Int J Cancer. 2007 Mar 1;120(5):1123-8.
  24. Genuis SJ, Schwalfenberg GK, Hiltz MN, Vaselenak SA. Vitamin D status of clinical practice populations at higher latitudes: analysis and applications. Int J Environ Res Public Health. 2009 Jan;6(1):151-73.
  25. Lissoni P. Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms. Pathol Biol (Paris). 2007 Apr-May;55(3-4):201-4.
  26. Cos S, Verduga R, Fernández-Viadero C, Megías M, Crespo D. Effects of melatonin on the proliferation and differentiation of human neuroblastoma cells in culture. Neurosci Lett. 1996 Sep 27;216(2):113-6.
  27. Martín V, Herrera F, Carrera-Gonzalez P, García-Santos G, Antolín I, et al. Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin. Cancer Res. 2006 Jan 15;66(2):1081-8.
  28. Wion D, Berger F, Wion-Barbot N. Glioma, melatonin, and radiotherapy. Cancer Res. 2006 Jun 15;66(12):6457.
  29. Gao L, Xu RK, Pang CS, Xu JP, Shan HM, Pang SF. [Inhibitory effect of melatonin on the development of pituitary prolactin-producing tumors induced by 17-beta-estradiol]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2001 Feb;23(1):49-53.
  30. Yang QH, Xu JN, Xu RK, Pang SF. Inhibitory effects of melatonin on the growth of pituitary prolactin-secreting tumor in rats. J Pineal Res. 2006 Apr;40(3):230-5.
  31. Sirachainan N, Wongruangsri S, Kajanachumpol S, Pakakasama S, Visudtibhan A, Nuchprayoon I, et al. Folate pathway genetic polymorphisms and susceptibility of central nervous system tumors in Thai children. Cancer Detect Prev. 2008;32(1):72-8.
  32. Bethke L, Webb E, Murray A, Schoemaker M, Feychting M, Lönn S, et al. Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1195-202
  33. Kafadar AM, Yilmaz H, Kafadar D, Ergen A, Zeybek U, Bozkurt N, et al. C677T gene polymorphism of methylenetetrahydrofolate reductase (MTHFR) in meningiomas and high-grade gliomas. Anticancer Res. 2006 May-Jun;26(3B):2445-9.
  34. Linnebank M, Semmler A, Moskau S, Smulders Y, Blom H, Simon M. The methylenetetrahydrofolate reductase (MTHFR) variant c.677C>T (A222V) influences overall survival of patients with glioblastoma multiforme. Neuro Oncol. 2008 Aug;10(4):548-52.
  35. Schueller P, Puettmann S, Micke O, Senner V, Schaefer U, Willich N. Selenium influences the radiation sensitivity of C6 rat glioma cells. Anticancer Res. 2004 Sep-Oct;24(5A):2913-7.
  36. Sundaram N, Pahwa AK, Ard MD, Lin N, Perkins E, Bowles AP Jr. Selenium causes growth inhibition and apoptosis in human brain tumor cell lines. J Neurooncol. 2000;46(2):125-33.
  37. Rooprai HK, Kyriazis I, Nuttall RK, Edwards DR, Zicha D, Aubyn D, et al. Inhibition of invasion and induction of apoptosis by selenium in human malignant brain tumour cells in vitro. Int J Oncol. 2007 May;30(5):1263-71.
  38. Kang YH, Lee E, Youk HJ, Kim SH, Lee HJ, Park YG, et al. Potentiation by alpha-tocopheryl succinate of the etoposide response in multidrug resistance protein 1-expressing glioblastoma cells. Cancer Lett. 2005 Jan 20;217(2):181-90.
  39. Borek C. Antioxidants and radiation therapy. J Nutr. 2004 Nov;134(11):3207S-3209S.
  40. Zhang, R. X., et al. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors. Chinese Medical Journal, 1990, 103, 658-665.
  41. Chen KT, Hao DM, Liu ZX, Chen YC, You ZS. Effect of berberine alone or in combination with argon ion laser treatment on 9L rat glioma cell line. Chin Med J (Engl). 1994 Nov;107(11):808-12.
  42. Wallace J. Integrative tumor board: Glioblastoma multiforme--Nutritional and botanical Approach. Integrative Cancer Therapies, Jun 2004;3(2): 149-72[152-63].
  43. Peng PL, Kuo WH, Tseng HC, Chou FP. Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death. Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):529-42.
  44. Liu SJ, Sun YM, Tian DF, He YC, Zeng L, He Y, et al. Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma. Br J Cancer. 2008 Jan 29;98(2):363-9.
  45. Liu Y, Yu H, Zhang C, Cheng Y, Hu L, Meng X, Zhao Y. Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer. Eur J Cancer. 2008 Nov;44(16):2425-32.
  46. Wang DY, Yeh CC, Lee JH, Hung CF, Chung JG. Berberine inhibited arylamine N-acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T/VGH) and brain glioblastoma multiforms (GBM 8401) cells. Neurochem Res. 2002 Sep;27(9):883-9
  47. Hung CF, Wong KT, Tsai CI, Lin CS, Chung JG. Arylamine N-acetyltransferase activity and 2 aminofluorene-DNA adducts formation in rat glial tumor cells. Acta Paediatr Taiwan. 2000 May-Jun;41(3):133-5.
  48. Yang J, Ljn J. [Advance on study in anti-tumor mechamism of bererine (Ber)] . Zhongguo Zhong Yao Za Zhi. 2007 May;32(10):881-3, 934.
  49. Eom KS, Hong JM, Youn MJ, So HS, Park R, Kim JM, et al. Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial/caspases pathway. Biol Pharm Bull. 2008 Apr;31(4):558-62.
  50. Chen TC, Lai KC, Yang JS, Liao CL, Hsia TC, Chen GW, et al. Involvement of reactive oxygen species and caspase-dependent pathway in berberine-induced cell cycle arrest and apoptosis in C6 rat glioma cells. Int J Oncol. 2009 Jun;34(6):1681-90.
  51. Pazhang Y, Ahmadian S, Mahmoudian M, Shafiezadeh M. Berberine-induced apoptosis via decreasing the survivin protein in K562 cell line. Med Oncol. 2010; DOI: 10.1007/s12032-010-9586-0 Online First™ .
  52. Pandey MK, Sung B, Kunnumakkara AB, Sethi G, Chaturvedi MM, Aggarwal BB. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res. 2008 Jul 1;68(13):5370-9.
  53. Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY, et al. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomedicine. 2010 May;17(6):436-40.
  54. Patil JB, Kim J, Jayaprakasha GK. Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway. Eur J Pharmacol. 2010 Oct 25;645(1-3):70-8.
  55. Lu B, Hu M, Liu K, Peng J. Cytotoxicity of berberine on human cervical carcinoma HeLa cells through mitochondria, death receptor and MAPK pathways, and in-silico drug-target prediction. Toxicol In Vitro. 2010a Sep;24(6):1482-1490.
  56. Pinto-Garcia L, Efferth T, Torres A, Hoheisel JD, Youns M. Berberine inhibits cell growth and mediates caspase-independent cell death in human pancreatic cancer cells. Planta Med. 2010 Aug;76(11):1155-61.
  57. Ho YT, Lu CC, Yang JS, Chiang JH, Li TC, Ip SW, et al. Berberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells. Anticancer Res. 2009 Oct;29(10):4063-70.
  58. Moussaieff A, Mechoulam R. Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials. J Pharm Pharmacol. 2009 Oct;61(10):1281-93.
  59. Janssen G, Bode U, Breu H, Dohrn B, Engelbrecht V, Göbel U. Boswellic acids in the palliative therapy of children with progressive or relapsed brain tumors. Klin Padiatr. 2000 Jul-Aug;212(4):189-95.
  60. Moussaieff A, Shein NA, Tsenter J, Grigoriadis S, Simeonidou C, Alexandrovich AG, et al. Incensole acetate: a novel neuroprotective agent isolated from Boswellia carterii. J Cereb Blood Flow Metab. 2008 Jul;28(7):1341-52.
  61. Weber CC, Reising K, Müller WE, Schubert-Zsilavecz M, Abdel-Tawab M. Modulation of Pgp function by boswellic acids. Planta Med. 2006 May;72(6):507-13.
  62. Gorman AM, Hirt UA, Orrenius S, Ceccatelli S. Dexamethasone pre-treatment interferes with apoptotic death in glioma cells. Neuroscience. 2000;96(2):417-25.
  63. Ní Chonghaile T, Concannon CG, Szegezdi E, Gorman AM, Samali A. Dexamethasone inhibits apoptosis in C6 glioma cells through increased expression of Bcl-XL. Apoptosis. 2006 Jul;11(7):1247-55.
  64. Qian YH, Xiao Q, Chen H, Xu J. Dexamethasone inhibits camptothecin-induced apoptosis in C6-glioma via activation of Stat5/Bcl-xL pathway. Biochim Biophys Acta. 2009 May;1793(5):764-71.
  65. Winking M, Sarikaya S, Rahmanian A, Jödicke A, Böker DK. Boswellic acids inhibit glioma growth: a new treatment option? J Neurooncol. 2000;46(2):97-103.
  66. Park YS, Lee JH, Bondar J, Harwalkar JA, Safayhi H, Golubic M. Cytotoxic action of acetyl-11-keto-beta-boswellic acid (AKBA) on meningioma cells. Planta Med. 2002 May;68(5):397-401
  67. Flavin DF. A lipoxygenase inhibitor in breast cancer brain metastases. J Neurooncol. 2007 Mar;82(1):91-3. Epub 2006 Sep 26.
  68. Karmakar S, Banik NL, Patel SJ, Ray SK. Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells. Neurosci Lett. 2006 Oct 16;407(1):53-8.
  69. Karmakar S, Banik NL, Ray SK. Curcumin suppressed anti-apoptotic signals and activated cysteine proteases for apoptosis in human malignant glioblastoma U87MG cells. Neurochem Res. 2007 Dec;32(12):2103-13.
  70. Luthra PM, Kumar R, Prakash A. Demethoxycurcumin induces Bcl-2 mediated G2/M arrest and apoptosis in human glioma U87 cells. Biochem Biophys Res Commun. 2009 Jul 10;384(4):420-5
  71. Bangaru ML, Chen S, Woodliff J, Kansra S. Curcumin (diferuloylmethane) induces apoptosis and blocks migration of human medulloblastoma cells. Anticancer Res. 2010 Feb;30(2):499-504.
  72. Elamin MH, Shinwari Z, Hendrayani SF, Al-Hindi H, Al-Shail E, Khafaga Y, et al. Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells. Mol Carcinog. 2010 Mar;49(3):302-14.
  73. Schaaf C, Shan B, Onofri C, Stalla GK, Arzt E, Schilling T, et al. Curcumin inhibits the growth, induces apoptosis and modulates the function of pituitary folliculostellate cells. Neuroendocrinology. 2010;91(2):200-10.
  74. Schaaf C, Shan B, Buchfelder M, Losa M, Kreutzer J, Rachinger W, et al. Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo. Endocr Relat Cancer. 2009 Dec;16(4):1339-50.
  75. Miller M, Chen S, Woodliff J, Kansra S. Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells. Endocrinology. 2008 Aug;149(8):4158-67.
  76. Choi BH, Kim CG, Bae YS, Lim Y, Lee YH, Shin SY. p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression.Cancer Res. 2008 Mar;68(5):1369-77.
  77. Lu DY, Leung YM, Cheung CW, Chen YR, Wong KL. Glial cell line-derived neurotrophic factor induces cell migration and matrix metalloproteinase-13 expression in glioma cells. Biochem Pharmacol. 2010 Oct 15;80(8):1201-9.
  78. Song H, Moon A. Glial cell-derived neurotrophic factor (GDNF) promotes low-grade Hs683 glioma cell migration through JNK, ERK-1/2 and p38 MAPK signaling pathways. Neurosci Res. 2006 Sep;56(1):29-38.
  79. Perry MC, Demeule M, Régina A, Moumdjian R, Béliveau R. Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts. Mol Nutr Food Res. 2010 Aug;54(8):1192-201.
  80. Purkayastha S, Berliner A, Fernando SS, Ranasinghe B, Ray I, Tariq H, et al. Curcumin Blocks Brain Tumor Formation. Brain Res. 2009 Feb;1266(17): 130-38.
  81. Dhandapani KM, Mahesh VB, Brann DW. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J Neurochem. 2007 Jul;102(2):522-38.
  82. Antony B, Merina B, Iyer VS, Judy N, Lennertz K, Joyal S. A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95CG (Biocurcumax), A Novel Bioenhanced Preparation of Curcumin. Indian J Pharm Sci. 2008 Jul-Aug;70(4):445-9.
  83. Merina B, Antony B. Bioavailability of Biocurcumax™ (BCM-95 ™) Spice India. 2006;19:11–15.
  84. Siegelin MD, Reuss DE, Habel A, Rami A, von Deimling A. Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells. Neuro Oncol. 2009 Apr;11(2):122-31.
  85. Braganhol E, Zamin LL, Canedo AD, Horn F, Tamajusuku AS, Wink MR, et al. Antiproliferative effect of quercetin in the human U138MG glioma cell line. Anticancer Drugs. 2006 Jul;17(6):663-71.
  86. Jakubowicz-Gil J, Langner E, Wertel I, Piersiak T, Rzeski W. Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line. Chem Biol Interact. 2010 Oct 6;188(1):190-203.
  87. Leone S, Fiore M, Lauro MG, Pino S, Cornetta T, Cozzi R. Resveratrol and X rays affect gap junction intercellular communications in human glioblastoma cells. Mol Carcinog. 2008 Aug;47(8):587-98
  88. Shao J, Li X, Lu X, Jiang C, Hu Y, Li Q, You Y, et al. Enhanced growth inhibition effect of Resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels. Colloids Surf B Biointerfaces. 2009 Aug 1;72(1):40-7
  89. Gagliano N, Aldini G, Colombo G, Rossi R, Colombo R, Gioia M, et al. The potential of resveratrol against human gliomas. Anticancer Drugs. 2010 Feb;21(2):140-50.
  90. Zamin LL, Filippi-Chiela EC, Dillenburg-Pilla P, Horn F, Salbego C, Lenz G. Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells. Cancer Sci. 2009 Sep;100(9):1655-62
  91. Holick CN, Smith SG, Giovannucci E, Michaud DS. Coffee, tea, caffeine intake, and risk of adult glioma in three prospective cohort studies. Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):39-47.
  92. Kang SS, Han KS, Ku BM, Lee YK, Hong J, Shin HY, et al. Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival. Cancer Res. 2010 Feb 1;70(3):1173-83.
  93. Sinn B, Tallen G, Schroeder G, Grassl B, Schulze J, Budach V, Tinhofer I. Caffeine confers radiosensitization of PTEN-deficient malignant glioma cells by enhancing ionizing radiation-induced G1 arrest and negatively regulating Akt phosphorylation. Mol Cancer Ther. 2010 Feb;9(2):480-8.
  94. Chalmers AJ, Ruff EM, Martindale C, Lovegrove N, Short SC. Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent. Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1511-9.
  95. Choi SY, Chung JH, Kim DH, Chung SW, Kim JY, Yu BP, Chung HY. Peroxisome proliferator- activated receptor gamma agonist action of 3-methyl-1,2-cyclopentanedione. Biochim Biophys Acta. 2007 Dec;1770(12):1612-9. Epub 2007 Aug 25.
  96. Grommes C, Landreth GE, Sastre M, Beck M, Feinstein DL, Jacobs AH, et al. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment. Mol Pharmacol. 2006 Nov;70(5):1524-33.
  97. Chearwae W, Bright JJ. PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells. Br J Cancer. 2008 Dec;99(12):2044-53.
  98. Karmakar S, Weinberg MS, Banik NL, Patel SJ, Ray SK. Activation of multiple molecular mechanisms for apoptosis in human malignant glioblastoma T98G and U87MG cells treated with sulforaphane. Neuroscience. 2006 Sep 1;141(3):1265-80.
  99. Jiang H, Shang X, Wu H, Huang G, Wang Y, Al-Holou S, et al. Combination treatment with resveratrol and sulforaphane induces apoptosis in human U251 glioma cells. Neurochem Res. 2010 Jan;35(1):152-61
  100. Porta N, Vallée L, Boutry E, Auvin S. [The ketogenic diet and its variants: state of the art]. Rev Neurol (Paris). 2009 May;165(5):430-9.
  101. Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, Seyfried TN. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab (Lond). 2007 Feb 21;4:5
  102. Nebeling LC, Miraldi F, Shurin SB, Lerner E. Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. J Am Coll Nutr. 1995 Apr;14(2):202-8.
  103. Zuccoli G, Marcello N, Pisanello A, Servadei F, Vaccaro S, Mukherjee P, Seyfried TN. Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report. Nutr Metab (Lond). 2010 Apr 22; 7:33.
  104. Seyfried TN, Kiebish MA, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P. Metabolic management of brain cancer. Biochim Biophys Acta. 2010 Sep 6. [Epub ahead of print]
  105. Mukherjee P, El-Abbadi MM, Kasperzyk JL, Ranes MK, Seyfried TN. Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br J Cancer. 2002 May 20;86(10):1615-21.
  106. Shelton LM, Huysentruyt LC, Mukherjee P, Seyfried TN. Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse. ASN Neuro. 2010 Jul 23;2(3):e00038
  107. Kouda K, Iki M. Beneficial effects of mild stress (hormetic effects): dietary restriction and health. J Physiol Anthropol. 2010;29(4):127-32.
  108. Seyfried TN, Kiebish M, Mukherjee P, Marsh J. Targeting energy metabolism in brain cancer with calorically restricted ketogenic diets. Epilepsia. 2008 Nov;49 Suppl 8:114-6.
  109. Wan G, Too HP. A specific isoform of GDNF family receptor alpha 1 regulates RhoA expression and glioma cell migration. J Neurochem. 2010 Aug 27.
  110. Hisaoka K, Takebayashi M, Tsuchioka M, Maeda N, Nakata Y, Yamawaki S. Antidepressants increase glial cell line-derived neurotrophic factor production through monoamine-independent activation of protein tyrosine kinase and extracellular signal-regulated kinase in glial cells. J Pharmacol Exp Ther. 2007 Apr;321(1):148-57. Epub 2007 Jan 8.
  111. Tsuchioka M, Takebayashi M, Hisaoka K, Maeda N, Nakata Y. Serotonin (5-HT) induces glial cell line-derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells. J Neurochem. 2008 Jul;106(1):244-57.
  112. Higgins SC, Pilkington GJ. The in vitro effects of tricyclic drugs and dexamethasone on cellular respiration of malignant glioma. Anticancer Res. 2010 Feb;30(2):391-7